Načítá se...
Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County
Background: Several placebo controlled studies have demonstrated the efficacy of infliximab in inflammatory bowel disease (IBD) but the potential toxicity of this new biological compound has been less studied. Aim: To assess the use of infliximab in IBD in a population based cohort, with special emp...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Copyright 2004 by Gut
2004
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1774085/ https://ncbi.nlm.nih.gov/pubmed/15138212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.018515 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|